Clinical trial
Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
NCT00098384 · DuPont, Hurbert L., MD, Other · Completed
Key facts
| NCT number | NCT00098384 |
|---|---|
| Title | Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea |
| Official title | A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria |
| Lead sponsor | DuPont, Hurbert L., MD, Other |
| Collaborators | Bausch Health Americas, Inc. Industry The University of Texas Health Science Center, Houston |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Drug |
| Interventions | rifaximin |
| Enrollment | 220 |
| Start date | Jun 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Dec 8, 2004 |
| Last update posted | May 9, 2006 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: